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Variations in the PCI to CABG ratio: Single centre
experience in Saudi Arabia & International
comparison
Ahmed A-Arifi, Hani K. Najm, Munir Ahmad,
Ali Al Ghamdi, Rawdene Van Onselen,
Muayed Al Zaibag
Objectives: Over the past 20 years, the use of percu-
taneous coronary intervention (PCI), for myocardial
revascularization has seen a dramatic turn, and increased
compared to coronary artery bypass graft (CABG). How-
ever, although the evidence available is similar, there are
a variation in the relative distribution of PCI to CABG
among centers and regions. We sought to study the dis-
tribution and ratio of the PCI to CABG in our center
and to compare it to the current international trend.
Methods and results: We carried a review of the
prospectively collected data on the annual cardiac proce-
dure reports a the King Abdulaziz Cardiac Centre,
Riyadh from 2001 through 2011, to identify the trends in
PCI and CABG variation over the study period, and to
compare it to the current world wide trend. Over the
studied period, the centre performed a total of 4313 and
2531 cases of PCI and CABG respectively. The isolated
CABG volume were static with an average 230 cases/year.
While the PCI volume shows a yearly almost 50%
increase with an average volume of 392 cases/year. PCI/
CABG ratio increased from 1.1 in 2001–2002 to 2.7 in
2011. In comparison to UK data, since 1998, the ratio of
PCI/CABG has increased from 1.1 to 3.1. In contrast in
New York, Manhattan programme, the PCI/CABG ratio
increased from 1.19 in 1994 to 8.04 in 2008. However,
the average ratio in the rest of the New York programme
is 3.31.
Conclusion: The current trend in our centre put us
in the medium to high group (2.7–3.2) of PCI to CABG
ratio and utilization. Further in-depth analysis of these
disparities may facilitate the selection of the most appro-
priate, effective, and evidence based revascularization
strategy. Hence, we recommend the implementation of
the appropriate criteria for PCI as a quality monitoring
in each centre.
http://dx.doi:10.1016/j.jsha.2013.03.036
Comparison of the sutureless (Perceval S) & The
transaortic (Core Valve) implantation (TAVI):
Echocardiographic valve haemodynamics and left
ventricular mass regression one year follow up
Ahmed A-Arifi, Hani K. Najm, AHMAD Omran,
Alaa A. Mohamed, Mohammed Balgaith,
Alc Algamdi, Munir Ahmad, Rawdene Van Onselen,
Muayed Al Zaibag
Objectives: The aim of this single centre study was
to compare early and 1-year echocardiographic outcomes
of patients undergoing trans-aortic aortic valve implanta-
tion (TAVI-Core Valve) versus patients undergoing
sutureless aortic valve replacement (Perceval-AVR) for
severe symptomatic aortic valve stenosis.
Methods and results: We reviewed the echocardio-
graphic hemodynamics of 22 cases of TAVIs (group A)
and 14 cases of Perceval-AVRs (group B), performed in
our centre from April 2010 to June 2012. Preoperative
characteristics of the two groups were comparable. Of
the Perceval patients 50% had concomitant CABG. We
performed a comparative analysis of the following echo-
cardiographic variables as in Table (1), assessed by two
experienced echocardiographer. The comparative analy-
sis were performed pre-discharge and up to 1-year follow
up. The echocardiographic data showed that the inci-
dence of paravalvular leak (at least mild) was greater in
the TAVI group (31.7% vs 0% P = .005). Valvular incompe-
tence was mild in 5 patients (22%) in group A and 3
patients (21%) in group B. There were no differences in
terms of average mean trans-prosthetic gradient
(9 mm Hg vs 13 mm Hg, P = .59) for (group A) and (group
B), respectively. Four patients (19%) in (group A), and one
patient (7%) in (group B) shows a reduction in the Ejec-
tion Fraction (EF). However, the EF shows significant
improvements in (group B) and no improvement in
(group A). Furthermore, the septal wall thickness and
posterior wall thickness reduction as a marker of left ven-
tricular mass regression were consistent with the changes
of the EF between the two groups.
Conclusion: This preliminary results shows that the
Perceval valve have an equivalent haemodynamic per-
formance to the Core Valve. However, the Perceval S
valve have a lower incidence of valvular and paravalvular
leak, and this have reflected on the improvements in the
left ventricular function and left ventricular mass regres-
sion up to 1 year.
http://dx.doi:10.1016/j.jsha.2013.03.037
Cardiac tumours: Ten-years single centre surgical
experience
Asad Khan, Mustafaf, Munir Ahmad, Hani Najm,
Rawdene Van Onselen, Ahmed Arifi
Objectives: To review all the patients referred for
cardiac surgery with the diagnosis of cardiac tumours,
from June 1999, till June 2012. The aim of the study was
to assess the clinical manifestations, pathology and surgi-
cal outcomes.
Methods and results: we retrospectively studied all
patients who were operated for cardiac tumours in our
centre, from 1999 to 2012. We analysed preoperative pre-
sentations, surgical procedure and postoperative out-
comes of these patients. During the study period, 16
patients underwent surgery for cardiac tumour. The
Mean age of patients was 43.37 years. There were more
female 62.5% (10) patients than male 37.5% (6). The main
clinical presentations of our patients were shortness of
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phy were the main diagnostic tool, however, other diag-
nostic modalities (C-MRI and C-CT) were helpful in
offering further diagnostic information and surgical plan-
ning. Of the 16 patients, 8 patients were operated on as
an urgent or emergency. Among the 16 patients, 9
(56.25%) patients were operated for Myxoma excision.
right ventricular sarcoma (1), metastactic leiomyosar-
coma (2), metastatic sacral sarcoma (1), and metastatic
renal cell carcinoma (2), and Bachets disease (1). There
were no in-hospital mortality and all patient had symp-
tomatic improvements.
Conclusion: Cardiac tumours still represent a chal-
lenging condition. Our review shows that metastatic
tumours represent almost 50% of all our cardiac tumours.
Appropriate available diagnostic modalities is crucial, as
currently prompt complete surgical removal is the only
therapeutic & palliative option and offers best chances
of survival.
http://dx.doi:10.1016/j.jsha.2013.03.038
Oral anticoagulation throughout pregnancy in
patients with mechanical heart valve prosthesis:
Safe alternatives
Ahmed Hassouna, Ahmed Teima, Ayman Ammar,
Yasser Elnahas, Mohamed Badawi
Objectives: Small dose of Warfarin (65 mg/day) was
suggested as being safe in pregnant patients with
mechanical heart valve prosthesis (MHVP) however; no
other oral anticoagulant (OA) alternative has been pro-
posed to cases failing to achieve their target INR. We
aimed to suggest the alternative use/shift of those cases
to our previously reported safe (OA) Phenindione
(6100 mg/day) and to compare both regimens.
Methods: Eighty-seven females with 106 bileaflet
MHVP implanted in the aortic (10; 11.5%), mitral (58;
66.7%) or both positions (19; 21.8%) continued OA
throughout pregnancy, with restriction of daily doses to
5 mg Warfarin or 100 mg Phenindione. Patients were
allowed to cross over if failed to achieve their target
INR: 2-3.5. Aspirin (100 mg/day) was supplemented,
starting second trimester.
Results: Out of 59 patients initially receiving Warfa-
rin, 15 (25.4%) shifted to Phenindione, compared to none
of 28 patients originally receiving Phenindione
(P = 0.002). Mean INR and daily OA dose for 44 patients
remaining on Warfarin and 43 patients receiving Phenin-
dione were: 2.39 ± 0.34 versus 2.25 ± 0.2 (P > 0.05) and
3.9 ± 1.07 mg versus 79.3 ± 18.5 mg; respectively. Mater-
nal complications were six cases of resolved vaginal
bleeding (6.9%). There were no cases of embryopathy
or prematurity. Fetal outcomes included 68 live births
(78.2%), seven abortions (8%), two fetal loss (2.3%); all
insignificantly related to OA dose or INR level.
Conclusion: Although 65 mg Warfarin per day can
be safe during pregnancy, yet it cannot always achieve
the target INR and 6100 mg of Phenindione can be con-
sidered as a comparatively safe alternative.
http://dx.doi:10.1016/j.jsha.2013.03.039
The aortic translocation (Nikaidoh) procedure: Ini-
tial experience
A. Elwy, A. Al Saeedi, H. Alqethamy, Y. AlFariedi,
A. Raghib, K. Alnajashi, A. Khoja, R. Di Donato
Prince Sultan Cardiac Center, Riyadh, Saudi Arabia
Objective: Midterm follow-up is analyzed after the
aortic translocation (Nikaidoh) procedure, an alternative
to the Rastelli procedure for ventriculoarterial discor-
dance, ventricular septal defect, and pulmonary stenosis
especially in cases with small or inlet VSD.
Methods: Seven patients underwent a Nikaidoh pro-
cedure at a median age of 3.3 years (0.9–9.3 years). The
native aortic valve was translocated from the right to
the left ventricular outflow tract by mobilization of the
aortic root.Four patients with coronary transfer as
the right coronary artery reimplanted as a button while
the other three patients had no coronary transfer. The
conal septum was divided in all patients. The right
ventricular outflow tract was reconstructed with valved
conduit. The median follow-up was 18 months (0.3–4
years). Left ventricular outflow tract obstruction and
aortic insufficiency were assessed by echocardiography.
Results: There were no deaths. Right ventricular to
Pulmonary artery conduit change were required in 2
patients (28.6%). No patient had any left ventricular out-
flow tract obstruction or aortic insufficiency more than
mild. All patients are doing well at last follow up.
Conclusion: The Nikaidoh is a valid alternative to
Rastelli or REV operations. It appears particularly indi-
cated in patients with TGA,VSD and LV outflow obstruc-
tion with small or inlet VSD.
http://dx.doi:10.1016/j.jsha.2013.03.040
Short-term outcome of coronary artery bypass graft
surgery in end stage renal failure dialysis-depen-
dent patients
Ahmed Ibrahim Rezk
Background: Patients with end-stage renal disease
(ESRD) requiring dialysis who undergo coronary artery
bypass graft surgery (CABG) are at significant risk for
perioperative morbidity and mortality. We describe our
own experience in such high risk subgroup of patients.
Methods: Over four years period, a retrospective
analysis of fifteen patients with dialysis-dependent renal
failure who underwent coronary artery bypass grafting.
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